AI in Diabetes Management: Global Market Outlook
Report Highlights
This report presents an in-depth assessment of the global market outlook for artificial intelligence (AI) in diabetes management. The study includes AI in diabetes management care platforms and associated services. It covers the impact of macroeconomic factors affecting the global market for AI in diabetes management. The report examines emerging market trends, and underlying future opportunities in the market. The report concludes with the company profiles of leading market participants and their offerings in AI in diabetes management products, solutions and services.
Report Includes
- A brief general outlook of the global market for artificial intelligence (AI) in diabetic management
- Analyses of the global market trends, with historic market revenue for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
- Understanding of the upcoming market potential for AI in diabetic mellitus management with an emphasis on new products and solutions/platform technologies, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for the AI in diabetic management market, and corresponding market share analysis product type, technique, and region
- In-depth information (facts and figures) on the major market dynamics, opportunities and gaps estimating the demand, technology adaptations in diabetes care, industry developments, regulatory dynamics, and Covid-19 impact on the progress of this market
- Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
- Company profiles of the major global players
Report Scope
In this report, the market has been segmented based on product type, technique and geographic region. The report provides an overview of the global market for AI in diabetes management and analyzes market trends. Using 2021 as the base year, the report provides estimated market data and revenue projections for the forecast period of 2022-2027. Market values have been estimated based on the total revenue of providers of AI in diabetes management products.
The scope of the study includes AI in diabetes management care platforms and associated services.
Frequently Asked Questions (FAQs)
- Technological Advances in Diabetes Preventive Care
- Growing Elderly Population
- Growing Demand for Real-time Monitoring and Improved Patient Engagement
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2021 |
| Forecast period considered | 2022 to 2027 |
| Base year market size | $457.4 million |
| Market size forecast | $2.1 billion |
| Growth rate | CAGR of 30.2% for the forecast period of 2022-2027 |
| Units considered | $ Millions |
| Segments covered | By Product Type, Technique, and Region |
| Regions covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA) |
| Key Market Drivers |
|
| Companies studied |
|